Skip to content

Long-term Effects of Endobronchial Valve Implantation on Cardiac Function and Skeletal Muscle Function

Long-term Effects of Endobronchial Valve Implantation on Cardiac Function and Skeletal Muscle Function in Patients With Lung Volume Reduction Surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05775588
Enrollment
22
Registered
2023-03-20
Start date
2023-03-27
Completion date
2024-12-31
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The goal of this type of study: clinical trial is to evaluate the effect of bronchial valve implantation on cardiac function and skeletal muscle function in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:evaluate the effect of bronchial valve implantation on cardiac function and skeletal muscle function. Participants will undergo Lung volume reduction surgery with endobronchial valve implantation.

Interventions

PROCEDURELung volume reduction surgery with endobronchial valve implantation

the patient would undergo Lung volume reduction surgery with endobronchial valve implantation

Sponsors

China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients with Chronic Obstructive Pulmonary Disease * FEV1 ≤ 45% pred and FEV1/FVC\<70% * TLC\>100% pred and RV\>175% pred * CAT score≥18 * Emphysema damage\>50% * Complete interlobar fissure \>95% based on quantitative analysis of CT measurement * No smoking\>6 months * Sign the informed consent form

Exclusion criteria

* PaCO2\>8.0 kPa, or PaO2\<6.0 kPa * 6-minute walk test\<160m * Obvious chronic bronchitis, bronchiectasis or other infectious pulmonary diseases * More than 3 hospitalizations for pulmonary infection in the past 12 months before baseline assessment * Previous lobectomy, LVRS or lung transplantation * LVEF\<45% and or RVSP\>50mmHg * Anticoagulant therapy that cannot be stopped before surgery * Patients with obvious immune deficiency * Participated in other lung drug studies within the first 30 days of this study * Pulmonary nodules requiring intervention * Any disease or condition that interferes with the completion of the initial or subsequent assessment

Design outcomes

Primary

MeasureTime frameDescription
Baseline ventricular volumeBaselinecardiac magnetic resonance imaging
Ventricular volume (6 months after surgery)6 months after surgerycardiac magnetic resonance imaging
Ventricular volume(12 months after surgery)12 months after surgerycardiac magnetic resonance imaging
Baseline FEV1BaselinePulmonary function tests
FEV1 (6 months after surgery)6 months after surgeryPulmonary function tests
FEV1(12 months after surgery)12 months after surgeryPulmonary function tests
Baseline left Ventricular Ejection FractionsBaselineEchocardiography
Left Ventricular Ejection Fractions (6 months after surgery)6 months after surgeryEchocardiography
Left Ventricular Ejection Fractions (12 months after surgery)12 months after surgeryEchocardiography
Baseline exercise toleranceBaseline6-minute walk test
Exercise tolerance (6 months after surgery)6 months after surgery6-minute walk test
Exercise tolerance (12 months after surgery)12 months after surgery6-minute walk test
Baseline health impairment and quality of life of patients Baseline health impairment and quality of life of patientsBaselineSt. George's Respiratory Questionnaire
Health impairment and quality of life of patients (6 months after surgery)6 months after surgerySt. George's Respiratory Questionnaire
Health impairment and quality of life of patients (12 months after surgery)12 months after surgerySt. George's Respiratory Questionnaire
Baseline cross sectional area of rectus femorisBaselineRectus femoris ultrasound
Cross sectional area of rectus femoris (6 months after surgery)6 months after surgeryRectus femoris ultrasound
Cross sectional area of rectus femoris (12 months after surgery)12 months after surgeryRectus femoris ultrasound
Baseline mmuscle strength of lower limbBaselineMyometer
Mmuscle strength of lower limb (6 months after surgery)6 months after surgeryMyometer
Mmuscle strength of lower limb (12 months after surgery)12 months after surgeryMyometer

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026